Who owns VOR?
Institutional ownership of Vor Biopharma Inc. from Form 13F, Q2 2026
102 institutional managers reported holding Vor Biopharma Inc. (VOR) in Form 13F filings for Q2 2026, with 49,352,382 shares worth $909M. The largest reported holder was TCG Crossover Management, LLC. Managers that filed both quarters added a net 8,901,594 shares (+22.0%). 38 opened new positions and 17 sold out.
- Funds holding
- 102
- Value held
- $909M
- New / sold out
- 38 / 17
- Net shares, same filers
- +22.0%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of VOR
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| TCG Crossover Management, LLC | $104M | 11.5% | 5,673,078 | Unchanged |
| FMR LLC | $90.8M | 10.0% | 4,932,149 | Added |
| FCPM III Services B.v. | $75.8M | 8.3% | 4,117,354 | Unchanged |
| BlackRock, Inc. | $63.8M | 7.0% | 3,468,107 | Added |
| Venrock Adviser, LLC | $56.0M | 6.2% | 3,041,719 | Unchanged |
| State Street Corp | $48.2M | 5.3% | 2,616,336 | Added |
| Frazier Life Sciences Management, L.P. | $46.8M | 5.2% | 2,543,939 | Unchanged |
| Ra Capital Management, L.p. | $44.2M | 4.9% | 2,402,095 | Trimmed |
| Vanguard Capital Management LLC | $38.4M | 4.2% | 2,084,328 | Added |
| Caligan Partners LP | $35.4M | 3.9% | 1,925,066 | Unchanged |
| Paradigm Biocapital Advisors LP | $32.2M | 3.5% | 1,750,000 | Unchanged |
| Great Point Partners LLC | $31.3M | 3.4% | 1,700,000 | Trimmed |
| Nantahala Capital Management, LLC | $31.1M | 3.4% | 1,690,000 | New |
| Geode Capital Management, LLC | $19.6M | 2.2% | 1,062,469 | Added |
| NEXTBio Capital Management LP | $16.4M | 1.8% | 889,164 | Trimmed |
| ADAR1 Capital Management, LLC | $12.5M | 1.4% | 680,626 | New |
| Logos Global Management LP | $12.0M | 1.3% | 650,000 | Trimmed |
| Rosalind Advisors, Inc. | $11.9M | 1.3% | 648,600 | Trimmed |
| Nan Fung Trinity (hk) LTD | $11.9M | 1.3% | 646,550 | New |
| Braidwell LP | $10.6M | 1.2% | 573,104 | Added |
| Boothbay Fund Management, LLC | $10.3M | 1.1% | 558,702 | Added |
| UBS Group AG | $9.1M | 1.0% | 493,278 | Added |
| Millennium Management LLC | $7.9M | 0.9% | 428,067 | Added |
| Sphera Funds Management LTD. | $7.7M | 0.8% | 416,417 | Added |
| Woodline Partners LP | $7.0M | 0.8% | 379,723 | New |
Share of 13F holdings is each fund's shares as a share of the 49,352,382 VOR shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- FMR LLC Added+$62.5M
- BlackRock, Inc. Added+$49.2M
- Nantahala Capital Management, LLC New+$31.1M
- State Street Corp Added+$27.6M
- Geode Capital Management, LLC Added+$13.3M
- ADAR1 Capital Management, LLC New+$12.5M
- Vanguard Capital Management LLC Added+$12.0M
- Nan Fung Trinity (hk) LTD New+$11.9M
- Woodline Partners LP New+$7.0M
- Vanguard Portfolio Management LLC New+$6.3M
Biggest sellers in Q2 2026
- Ra Capital Management, L.p. Trimmed-$55.3M
- Marshall Wace, LLP Trimmed-$19.5M
- Laurion Capital Management LP Sold out-$5.7M
- Propel Bio Management, LLC Sold out-$5.6M
- Susquehanna International Group, LLP Trimmed-$4.0M
- Tudor Investment Corp Et Al Trimmed-$2.4M
- NEXTBio Capital Management LP Trimmed-$2.0M
- Jump Financial, LLC Trimmed-$1.9M
- Logos Global Management LP Trimmed-$1.8M
- Renaissance Technologies LLC Trimmed-$1.8M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $275M and sold $110M; 35 added and 19 trimmed.
Schedule 13D and 13G filings on VOR
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-08-06FMR LLC SCHEDULE 13G filed by Vor Biopharma Inc.Schedule 13G
- 2026-07-30BlackRock, Inc. SCHEDULE 13G filed by BlackRock Inc.Schedule 13G
- 2025-12-17GREAT POINT PARTNERS LLC SCHEDULE 13G filed by Vor Biopharma Inc.Schedule 13G
- 2025-11-07FMR LLC SCHEDULE 13G filed by Vor Biopharma Inc.Schedule 13G
- 2025-09-26Venrock Healthcare Capital Partners III, L.P. SCHEDULE 13G filed by Vor Biopharma Inc.Schedule 13G
Questions about VOR ownership
- Who owns VOR stock?
- 102 institutional investment managers reported VOR positions in their Form 13F filings for Q2 2026, holding 49,352,382 shares worth $909M in total. TCG Crossover Management, LLC reported the largest position.
- Are funds buying or selling VOR?
- In Q2 2026, 38 managers opened new VOR positions, 35 added, 19 trimmed and 17 sold out. Managers that filed in both quarters added a net 8,901,594 shares.
- How current is this VOR institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to VOR by CUSIP. Options are left out. VOR news and filings · VOR insider trades · Top funds